Respiratory Syntactical Virus (RSV) Market, By Drugs Type (Palivizumab, and Ribavirin), By Dosage Form (Oral, and Injectable), By Diagnostics Method (Rapid Antigen Diagnostic Test, Direct Fluorescent Antibody Method, Gel Microdroplets, Chromatographic Immunoassay, Molecular Diagnostics, Diagnostic Imaging, and Flow Cytometry), By End-Use (Drug Stores and Retail Pharmacies, Hospitals and Clinics, and Clinical Laboratories) - Analysis & Forecast 2020-2030

Report ID : 416  |  Published Date : Jan 2021  |  Pages : 150  |  Region : Global  |  Report Code : HC-223




Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Classification
    3. Geographic Scope
    4. Years Considered for the Study:
      1. Historical Years – 2017 & 2018
      2. Base Year – 2019
      3. Forecasted Years – 2020 to 2030
    5. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1. Bottom Up Approach
      2. Top Down Approach
    5. Data Validation and Triangulation
      1. Market Forecasting Model
      2. Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITION (USP)
    1. COVID-19 Impact Assessment on Respiratory Syntactical Virus (RSV) Market
  6. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV) MARKET - ANALYSIS & FORECAST, BY DRUGS TYPE
    1. Palivizumab
    2. Ribavirin
    3. Others
  7. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV) MARKET - ANALYSIS & FORECAST, BY DOSAGE FORM
    1. Oral
    2. Injectable
    3. Others
  8. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV)MARKET - ANALYSIS & FORECAST, BY  DIAGNOSTICS METHODS
    1. Direct Fluorescent Antibody (DFA) Method
    2. Rapid Antigen Diagnostic Test (RADTs)
    3. Molecular Diagnostics
    4. Chromatographic Immunoassay
      1.       Gravity Driven Test
      2.       Oligochromatography (OC)
    5. Diagnostic Imaging
    6. Gel Microdroplets
    7. Flow Cytometry
    8. Others
  9. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV) MARKET - ANALYSIS & FORECAST, BY END USE
    1. Hospitals and Clinics
    2. Drug Stores and Retail Pharmacies
    3. Clinical Laboratories
    4. Others
  10. GLOBAL Respiratory Syntactical Virus (RSV)MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Respiratory Syntactical Virus (RSV) Market
      1. North America Respiratory Syntactical Virus (RSV) Market, By Country
        1.  US
        2.  Canada
      2. North America Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Drugs Type
      3. North America Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Dosage Form
      4. North America Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Diagnostics Method
      5. North America Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By End Use
    2. Europe Respiratory Syntactical Virus (RSV) Market
      1. Europe Respiratory Syntactical Virus (RSV) Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Drugs Type
      3. Europe Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Dosage Form
      4. Europe Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Diagnostics Method
      5. Europe Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By End Use
    3. Asia Pacific Respiratory Syntactical Virus (RSV) Market
      1. Asia Pacific Respiratory Syntactical Virus (RSV) Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Drugs Type
      3. Asia Pacific Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Dosage Form
      4. Asia Pacific Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Diagnostics Method
      5. Asia Pacific Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By End Use
    4. Rest of the World (ROW) Respiratory Syntactical Virus (RSV) Market
      1. Rest of the World Respiratory Syntactical Virus (RSV) Market, By Country/ Region
        1. Latin America
        2. Middle East & Africa
      2. Rest of the World Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Drugs Type
      3. Rest of the World Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Dosage Form
      4. Rest of the World Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By Diagnostics Method
      5. Rest of the World Respiratory Syntactical Virus (RSV) Market Analysis & Forecast, By End Use
  11. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, Recent Developments)*
    1. Abbott Laboratories
    2. AbbVie, Inc.
    3. AstraZeneca plc.
    4. Becton, Dickinson and Company (BD)
    5. Biocartis Group
    6. BioMérieux SA
    7. Danaher Corporation
    8. F. Hoffmann-La Roche Ltd.
    9. Fast Track Diagnostics Luxembourg S.à r.l.
    10. Gilead Sciences, Inc.
    11. GlaxoSmithKline plc.
    12. Hologic, Inc.
    13. Luminex Corporation
    14. MEDIVIR AB
    15. Merck & Co., Inc.
    16. ReViral Ltd.
    17. Teva Pharmaceuticals Industries Ltd.
    18. Thermo Fisher Scientific Inc.
    19. Valeant Pharmaceuticals International, Inc.

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain